FDA GRANTS ORPHAN DRUG DESIGNATION TO AFFINIA THERAPEUTICS’ AFTX-201 FOR THE TREATMENT OF BAG3-ASSOCIATED DILATED CARDIOMYOPATHY (DCM)

Reuters · 3d ago

Please log in to view news